论文信息 - NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis - 字舞流文

NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis

M. Raffeld | S. Rosenberg | P. Robbins | M. Tsokos | M. Miettinen | P. Aung | C. Lee | Jin-Ping Lai

[1] M. Miettinen. A Simple Method for Generating Multitissue Blocks Without Special Equipment , 2012, Applied immunohistochemistry & molecular morphology : AIMM.

[2] D. Jäger,et al. Protein expression of cancer testis antigens predicts tumor recurrence and treatment response to imatinib in gastrointestinal stromal tumors , 2011, International journal of cancer.

[3] M. Raffeld,et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4] Heng-hui Zhang,et al. Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues. , 2009, Oncology reports.

[5] M. Raffeld,et al. MDM2 Antagonist Nutlin-3 Displays Antiproliferative and Proapoptotic Activity in Mantle Cell Lymphoma , 2009, Clinical Cancer Research.

[6] N. Demartines,et al. Cancer testis antigen expression in gastrointestinal stromal tumors: New markers for early recurrence , 2008, International journal of cancer.

[7] M. Ladanyi,et al. Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen ny‐eso‐1 but not mage‐a1 or ct7 , 2001, International journal of cancer.

[8] F. Tanaka,et al. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas , 2001, British Journal of Cancer.